Using spectral CT scans for cervical cancer radiotherapy
Official title: The Clinical Research of Spectral CT in Radiotherapy for Cervical Cancer
Run by Peking Union Medical College Hospital · NCT06433817 · Data updated 2026-11-12
This study is testing if special CT scans can help improve treatment planning and monitoring for patients with cervical cancer who are receiving chemotherapy and radiation.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 150 (estimated) |
| Sponsor | Peking Union Medical College Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | May 22, 2024 |
| Main results expected | May 22, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | May 30, 2024 |
| Trial ID | NCT06433817 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients diagnosed with cervical cancer who are receiving concurrent chemoradiotherapy.
✕Probably not a fit
Patients who have not undergone spectral CT scans or those with a history of allergy to intravenous contrast may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the application of spectral computed tomography (CT) in the context of radiotherapy for patients with cervical cancer. It involves patients who have been diagnosed with cervical cancer and are undergoing concurrent chemoradiotherapy, with spectral CT scans being performed during both the arterial and venous phases. The study seeks to evaluate how spectral CT can enhance treatment planning and monitoring in this patient population.
Why it matters
Potential benefit: If successful, this approach could improve the precision of radiotherapy for cervical cancer patients, potentially leading to better treatment outcomes.
How similar studies have gone: While the application of spectral CT in radiotherapy is a relatively novel approach, there have been some preliminary studies suggesting its potential benefits in similar contexts.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. All patients were confirmed cervical cancer by pathology 2. patients were treated with concurrent chemoradiotherapy 3. Spectral CT scans acquisition performed during the arterial phase and venous phase 4. All the patients underwent a 18F-FDG PET/CT before treatment Exclusion Criteria: 1. CT without spectral scans 2. History of allergy to intravenous contrast 3. Pregnant or potentially pregnant female subjects
Where it's running
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Fuquan Zhang, Porf
- Email: zhangfq@pumch.cn
- Phone: 86 01069154072
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Analysis of outcomes and side effects in patients receiving radiation therapy
This study looks at the results and side effects of radiation therapy in patients at Winterthur Cantonal Hospital to see how treatment can be improved for future patients.
-
Cervical screening and care options for women living with HIV who test positive for high-risk HPV
This study tests different ways to screen and manage high-risk HPV in women with HIV to see what might work best for them.
-
Hydrogel spacer to protect the rectum during cervical cancer radiotherapy
This study tests whether placing an absorbable hydrogel spacer between the cervix/vagina and rectum before definitive radiotherapy can reduce rectal radiation exposure for women with cervical cancer.
-
How cinema sessions during chemotherapy might help cervical cancer patients
We’re testing if watching films during chemotherapy helps cervical cancer patients feel less anxious and improve quality of life.
-
One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy
This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.
-
Primary tumor removal with targeted lymph node removal plus radiation for biliary tract cancer with lymph node spread
This phase II study tests whether removing the main tumor and select nearby lymph nodes, followed by postoperative radiation, helps patients with biliary tract cancer and lymph node metastases.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.